236 related articles for article (PubMed ID: 19760337)
1. A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model.
George AJ; Gordon L; Beissbarth T; Koukoulas I; Holsinger RM; Perreau V; Cappai R; Tan SS; Masters CL; Scott HS; Li QX
Neurotox Res; 2010 May; 17(4):360-79. PubMed ID: 19760337
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.
Reddy PH; McWeeney S; Park BS; Manczak M; Gutala RV; Partovi D; Jung Y; Yau V; Searles R; Mori M; Quinn J
Hum Mol Genet; 2004 Jun; 13(12):1225-40. PubMed ID: 15115763
[TBL] [Abstract][Full Text] [Related]
3. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease.
Tsai KJ; Yang CH; Lee PC; Wang WT; Chiu MJ; Shen CK
Neuroscience; 2009 Mar; 159(2):638-46. PubMed ID: 19167467
[TBL] [Abstract][Full Text] [Related]
5. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
Calon F; Lim GP; Morihara T; Yang F; Ubeda O; Salem N; Frautschy SA; Cole GM
Eur J Neurosci; 2005 Aug; 22(3):617-26. PubMed ID: 16101743
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
7. Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain.
Heiland T; Zeitschel U; Puchades MA; Kuhn PH; Lichtenthaler SF; Bjaalie JG; Hartlage-Rübsamen M; Roßner S; Höfling C
Glia; 2019 Feb; 67(2):393-403. PubMed ID: 30485540
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
[TBL] [Abstract][Full Text] [Related]
11. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease.
Escrig A; Canal C; Sanchis P; Fernández-Gayol O; Montilla A; Comes G; Molinero A; Giralt M; Giménez-Llort L; Becker-Pauly C; Rose-John S; Hidalgo J
Brain Behav Immun; 2019 Nov; 82():145-159. PubMed ID: 31401302
[TBL] [Abstract][Full Text] [Related]
12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
13. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
14. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
15. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E.
Selwood SP; Parvathy S; Cordell B; Ryan HS; Oshidari F; Vincent V; Yesavage J; Lazzeroni LC; Murphy GM
Neurobiol Aging; 2009 Apr; 30(4):574-90. PubMed ID: 17904698
[TBL] [Abstract][Full Text] [Related]
17. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
[TBL] [Abstract][Full Text] [Related]
18. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
19. An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw mice.
Zhuo JM; Prakasam A; Murray ME; Zhang HY; Baxter MG; Sambamurti K; Nicolle MM
Curr Alzheimer Res; 2008 Aug; 5(4):385-91. PubMed ID: 18690835
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
